Ultragenyx Pharmaceutical Inc. (RARE) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$2,375
Total Return
-76.25%
CAGR
-24.99%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.32% |
| Median | -2.31% |
| Best | +36.57% |
| Worst | -41.59% |
| % of Windows Positive | 42.3% |
1-Year (252 Trading Days)
| Average | -18.32% |
| Median | -23.47% |
| Best | +77.31% |
| Worst | -58.86% |
| % of Windows Positive | 24.0% |
3-Year (756 Trading Days)
| Average | -39.45% |
| Median | -41.29% |
| Best | +2.97% |
| Worst | -62.04% |
| % of Windows Positive | 0.8% |
Risk Metrics
| Maximum Drawdown | -82.02% |
| Average Drawdown | -53.16% |
| Drawdown Duration | 1248 Trading Days (Unrecovered) |
| Sortino Ratio | -0.33 |
| Calmar Ratio | -0.30 |
| CVaR (5%) | -7.94% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -2.57% (-5.98% ann.) | $256.53 | $0.00 | $0.00 | $0.00 |
| 2025 | -45.33% | $4532.92 | $0.00 | $0.00 | $0.00 |
| 2024 | -12.02% | $1202.42 | $0.00 | $0.00 | $0.00 |
| 2023 | +3.22% | +$321.60 | $0.00 | $0.00 | $0.00 |
| 2022 | -44.90% | $4490.43 | $0.00 | $0.00 | $0.00 |
| 2021 | -39.25% | $3925.45 | $0.00 | $0.00 | $0.00 |
| 2020 | +224.12% | +$22411.60 | $0.00 | $0.00 | $0.00 |
| 2019 | -1.77% | $177.08 | $0.00 | $0.00 | $0.00 |
| 2018 | -6.25% | $625.28 | $0.00 | $0.00 | $0.00 |
| 2017 | -34.03% | $3403.50 | $0.00 | $0.00 | $0.00 |
| 2016 | -37.32% | $3732.39 | $0.00 | $0.00 | $0.00 |
| 2015 | +155.65% | +$15565.18 | $0.00 | $0.00 | $0.00 |
| 2014 partial | +3.86% (+4.23% ann.) | +$385.80 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | January 31, 2014 – February 19, 2020 | +45.68% | +6.42% | +$4568.05 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -37.34% | -99.52% | $3733.77 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +168.55% | +390.12% | +$16854.66 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -35.18% | -33.73% | $3518.29 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -55.18% | -57.35% | $5517.74 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +55.64% | +26.96% | +$5564.14 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -61.16% | -42.56% | $6116.12 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.